TuHURA Biosciences Statistics
Share Statistics
TuHURA Biosciences has 42.28M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 42.28M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 140 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
| Short Interest | 0 |
| Short % of Shares Out | 0% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -452.28 and the forward PE ratio is null.
| PE Ratio | -452.28 |
| Forward PE | null |
| PS Ratio | 0 |
| Forward PS | 2.9 |
| PB Ratio | -8506.41 |
| P/FCF Ratio | -1102.18 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for TuHURA Biosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of -1.49.
| Current Ratio | 1.16 |
| Quick Ratio | 1.16 |
| Debt / Equity | -1.49 |
| Total Debt / Capitalization | 303.65 |
| Cash Flow / Debt | -5.14 |
| Interest Coverage | -1592.72 |
Financial Efficiency
Return on equity (ROE) is 18.81% and return on capital (ROIC) is -3785.74%.
| Return on Equity (ROE) | 18.81% |
| Return on Assets (ROA) | -6.72% |
| Return on Capital (ROIC) | -3785.74% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.67M |
| Employee Count | 11 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -1 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -97.03% in the last 52 weeks. The beta is 0, so TuHURA Biosciences 's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -97.03% |
| 50-Day Moving Average | 4.76 |
| 200-Day Moving Average | 171.45 |
| Relative Strength Index (RSI) | 36.27 |
| Average Volume (20 Days) | 312.99K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -29.76M |
| Net Income | -29.32M |
| EBITDA | -29.12M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 3.67M in cash and 2.34M in debt, giving a net cash position of 1.32M.
| Cash & Cash Equivalents | 3.67M |
| Total Debt | 2.34M |
| Net Cash | 1.32M |
| Retained Earnings | -88.47M |
| Total Assets | 4.14M |
| Working Capital | 1.23M |
Cash Flow
In the last 12 months, operating cash flow was -11.95M and capital expenditures -79.22K, giving a free cash flow of -12.03M.
| Operating Cash Flow | -11.95M |
| Capital Expenditures | -79.22K |
| Free Cash Flow | -12.03M |
| FCF Per Share | -0.18 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HURA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.59% |
| FCF Yield | -6.14% |
Analyst Forecast
The average price target for HURA is $11, which is 137.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $11 |
| Price Target Difference | 137.6% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 14, 2022. It was a backward split with a ratio of 1:50.
| Last Split Date | Nov 14, 2022 |
| Split Type | backward |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | -17.51 |
| Piotroski F-Score | 2 |